Bullish Moving Averages
2
Bearish Moving Averages
14
Back Stocks profile
Stock analysis tool for investors
Performance
Open Price
144.80Prev. Close
159.5000Volume
1000.00Value
145000.00Fundamentals
Market Cap Cr
24.40
Price to Earnings
0.00
Price to Book Value
2.90
Dividend Yield
0.00
PE to Growth
0.00
Op Revenue TTM Cr
0.00
Net Profit TTM Cr
0.00
Cash From Operating Activity Cr
-0.79
Return on Equity %
6.84
EMA & SMA
DELIVERY AND VOLUME
DAILY AVG. DELIVERY VOLUME %
08 May, 2024
100
Week
100
Month
LEGEND
Positive Indicator
Neutral Indicator
Negative Indicator
RESISTANCE AND SUPPORT
144.95
PIVOT
First Resistance
145.05
Second Resistance
145.10
Third Resistance
145.20
First Support
144.90
Second Support
144.80
Third Support
144.75
Relative Strength Index
46.42
Money Flow Index
19.32
MACD
-3.1
MACD Signal
-4.35
Average True Range
7.22
Average Directional Index
13.93
Rate of Change (21)
-0.48
Rate of Change (125)
-34.68
Commodity Channel Index
18.1
Williams %R
-59.3
BETA
1 Month
1.23
3 Month
0
1 Year
-0.3
3 Year
PRICE CHANGE ANALYSIS
↑ 1.4%
1 Week
Low
High
143
145
↑ 2.84%
1 Month
Low
High
134
161
↓ -17.4%
3 Months
Low
High
134
199.5
↓ -27.48%
6 Months
Low
High
134
226
↓ -29.47%
1 Year
Low
High
134
254
30 Apr 2024
EP Biocomposites Ltd - 543595 - Regu. 7 (3) Compliance Certificate For The Financial Year 2023-24
Regu. 7 (3) Compliance Certificate for the Financial Year 2023-24
30 Apr 2024
EP Biocomposites Ltd - 543595 - Certificate Under Regulation 40 (9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
With reference to the above, certificate received from Bigshare Services Private Limited, RTA of the Company, is hereby enclosed.
30 Mar 2024
EP Biocomposites Ltd - 543595 - Closure of Trading Window
This is to inform you that the Company has closed the trading window for the earnings release of the financial year ending March 31, 2024 in compliance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, as amended from time to time, from April 1, 2024.
31 Jan 2024
EP Biocomposites Ltd - 543595 - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015- Award Of Order
The Company has received an order of INR 4.9 Crores for the construction of 4 intermediate pumping stations (manhole to manhole) and raising main in Taleigao constituency, Goa.
29 Nov 2023
EP Biocomposites Ltd - 543595 - Award Of An Order For Design, Supply, Installation, Testing And Commissioning Of Sewage Treatment Plant (STP) Of 100 KLD Capacity (MBR Based)
Award of an order for design, supply, installation, testing and commissioning of sewage treatment plant (STP) of 100 KLD capacity (MBR based) from Oil and Natural Gas Corporation Limited
14 Nov 2023
EP Biocomposites Ltd - 543595 - Unaudited Financial Results For The Half Year Ended September 30, 2023 With Statement Of Assets And Liabilities
Unaudited financial results for the half year ended September 30, 2023 duly approved by the Board of Directors of the Company in their meeting held today along with the Limited Review Report by the Auditors of the Company
14 Nov 2023
EP Biocomposites Ltd - 543595 - Board Meeting Outcome for Outcome Of The Intimation Of The Board Meeting
The unaudited Financial Results for the Half Year ended September 30, 2023 were duly approved by the Board of Directors of the Company in their meeting held today i.e. November 14, 2023 together with Statement of Assets and Liabilities
08 Nov 2023
EP Biocomposites Ltd - 543595 - Board Meeting Intimation for The Consideration And Approval Of Draft Financial Results For The Half Year Ended September 30, 2023
EP Biocomposites Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results for half-year ended September 30, 2023.
06 Oct 2023
EP Biocomposites Ltd - 543595 - Intimation Under Regulation 30 (LODR)
Resignation of Company Secretary and Compliance Officer
11 Sep 2023
EP Biocomposites Ltd - 543595 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Covering Letter along with Report under Regulation 44 and Scrutinizer''s Report
